Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DEM Solutions is a leading provider of Discrete Element Method (DEM) simulation software, primarily known for its flagship product, EDEM. The company serves the pharmaceutical and life sciences industries by providing advanced tools to simulate and optimize the behavior of bulk materials, such as powders, granules, and tablets, during the manufacturing process. Its technology is used to model critical operations including mixing, milling, tablet coating, and die filling, helping pharmaceutical engineers ensure product uniformity and reduce manufacturing waste. By enabling virtual prototyping, the software accelerates process scale-up and supports Quality by Design (QbD) initiatives. In November 2019, DEM Solutions was acquired by Altair Engineering, integrating its particle simulation capabilities into Altair's broader computer-aided engineering (CAE) portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DEM Solutions.